RX MEDSYNC

Serial Number 86125212
Registration 4740006
800

Registration Progress

Application Filed
Nov 21, 2013
Under Examination
Jan 27, 2015
Approved for Publication
Dec 2, 2014
Published for Opposition
Dec 2, 2014
Registered
May 19, 2015

Basic Information

Serial Number
86125212
Registration Number
4740006
Filing Date
November 21, 2013
Registration Date
May 19, 2015
Published for Opposition
December 2, 2014
Renewal Date
May 19, 2025
Drawing Code
4

Status Summary

Current Status
Active
Status Code
800
Status Date
Jun 28, 2025
Registration
Registered
Classes
035 044

Rights Holder

Thrifty Drug Stores, Inc.

03
Address
6055 Nathan Lane North
Suite #200
Plymouth, MN 55442

Ownership History

Thrifty Drug Stores, Inc.

Original Applicant
03
Plymouth, MN

Thrifty Drug Stores, Inc.

Owner at Publication
03
Plymouth, MN

Thrifty Drug Stores, Inc.

Original Registrant
03
Plymouth, MN

Legal Representation

Attorney
Cynthia A. Moyer
USPTO Deadlines 0 active
All 4 deadline(s) have been cleared by subsequent events. No active deadlines at this time.

Application History

38 events
Date Code Type Description
Jun 28, 2025 NA89 E NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
Jun 28, 2025 RNL1 Q REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
Jun 28, 2025 89AG O REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
Jun 28, 2025 APRE A CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Jan 21, 2025 E89R I TEAS SECTION 8 & 9 RECEIVED
May 19, 2024 REM2 E COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
Jun 16, 2023 TCCA I TEAS CHANGE OF CORRESPONDENCE RECEIVED
Jun 16, 2023 ARAA I ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Jun 16, 2023 REAP I TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
May 9, 2022 NA85 E NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
May 9, 2022 C15A O REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
May 7, 2022 APRE A CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Nov 12, 2021 E815 I TEAS SECTION 8 & 15 RECEIVED
May 19, 2020 REM1 E COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
May 19, 2015 R.PR A REGISTERED-PRINCIPAL REGISTER
Apr 16, 2015 SUNA E NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Apr 15, 2015 CNPR P ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Mar 31, 2015 SUPC I STATEMENT OF USE PROCESSING COMPLETE
Mar 30, 2015 AITU A CASE ASSIGNED TO INTENT TO USE PARALEGAL
Feb 25, 2015 IUAF S USE AMENDMENT FILED
Feb 25, 2015 EISU I TEAS STATEMENT OF USE RECEIVED
Jan 27, 2015 NOAM E NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Dec 2, 2014 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Dec 2, 2014 PUBO A PUBLISHED FOR OPPOSITION
Nov 12, 2014 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Oct 25, 2014 PREV O LAW OFFICE PUBLICATION REVIEW COMPLETED
Oct 25, 2014 ALIE A ASSIGNED TO LIE
Oct 6, 2014 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER
Sep 11, 2014 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED
Sep 10, 2014 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE
Sep 10, 2014 TROA I TEAS RESPONSE TO OFFICE ACTION RECEIVED
Mar 10, 2014 GNRN O NOTIFICATION OF NON-FINAL ACTION E-MAILED
Mar 10, 2014 GNRT F NON-FINAL ACTION E-MAILED
Mar 10, 2014 CNRT R NON-FINAL ACTION WRITTEN
Mar 7, 2014 DOCK D ASSIGNED TO EXAMINER
Dec 6, 2013 MPMK E NOTICE OF PSEUDO MARK E-MAILED
Dec 5, 2013 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Nov 25, 2013 NWAP I NEW APPLICATION ENTERED

Detailed Classifications

Class 035
Pharmacy services, namely, providing customer prescription drug and related products filling and refilling services; retail pharmacy services, namely, coordinating with physicians and pharmacists so that multiple prescriptions are prepared and available on the same day
First Use Anywhere: 20140400
First Use in Commerce: 20140400
Class 044
Providing virtual and in-person medication consultation and advice, in the nature of pharmaceutical advice, medical and pharmaceutical consultation
First Use Anywhere: 20140400
First Use in Commerce: 20140400

Additional Information

Pseudo Mark
RX MED SYNC

Classification

International Classes
035 044

Disclaimers

The following terms have been disclaimed and are not claimed as part of the trademark:
Specific Disclaimer
"RX"